Alamar Biosciences Quarterly Cash Flow Statement
NASDAQ: ALMRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 25.74 +1.86%
Alamar Biosciences free cash flow
In the quarter ended Jun 30, 2026, Alamar Biosciences generated -$11.3 million of operating cash flow and spent $3.6 million on capital expenditures. That left free cash flow of -$15.0 million, a free-cash-flow margin of -50.9% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Alamar Biosciences cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Net Income | -13.20M | -21.32M | -7.02M | -7.66M |
| Net Income growth (YoY) | — | — | — | — |
| Depreciation & Amortization | 1.13M | 1.17M | 919.00K | 888.00K |
| Stock-Based Compensation | 3.28M | 1.47M | 680.00K | 619.00K |
| Change in Working Capital | -1.27M | -8.74M | -11.03M | -2.12M |
| Operating Cash Flow | -11.32M | -20.35M | -11.88M | -13.07M |
| Capital Expenditures | -3.64M | -600.00K | -753.00K | -554.00K |
| Investing Cash Flow | -120.80M | -778.00K | 17.95M | 17.02M |
| Financing Cash Flow | 201.84M | 55.76M | 164.00K | 243.00K |
| Net Change in Cash | 69.73M | 34.58M | 6.56M | 4.33M |
| Free Cash Flow | -14.96M | -20.95M | -12.63M | -13.62M |
This table shows 4 quarterly periods of Alamar Biosciences's cash flow statement, from Q2 2026 back to Q? 2025, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ALMR's reporting calendar. What is a cash flow statement?